To Congress
HLC joint letter urging Congress to pass legislation to fix the disparity in the IRA that subjects small molecule medicines to price setting sooner than biologics
- Topics: Competition, Innovation
Related Letters & Comments
HLC drives policy change through strategic letters, comments, and reports that promote private-sector innovation. Focused on priorities like Medicare reform, telehealth, and health equity, HLC engages with lawmakers and agencies to shape a smarter, more responsive healthcare system.
To The Administration
HLC comments support strengthening intellectual property provisions of USMACA
To The Administration
HLC response to the Federal Trade Commission’s RFI regarding noncompete agreements
To Congress
